Table 1.
Anthropometric and social background data, degree of physical activity, number of medications and data on those who used at least one prescription drug in people with obesity (BASUN) and the reference population from the WHO-MONICA study, Gothenburg, Sweden.
Fig 1.
Results from a multiple linear regression for evaluation of association between health-related quality of life indicated by the Rand-36 and SRH-VAS instruments and weight category (BASUN population with obesity and reference MONICA population).
The model is adjusted for age and number of medication (Meds) and results presented as beta coefficients with 95% confidence intervals.
Table 2.
Health-related quality of life (HRQoL) measured with RAND-36/Short Form-36 (SF-36) and SRH-VAS in people with obesity (BASUN) and a reference population from the WHO-MONICA study, Gothenburg, Sweden.
Mean values are given for all subscales.
Fig 2.
Results of a multiple linear regression for evaluation of association between health-related quality of life indicated by the Rand-36 instrument and BMI category (BASUN population with obesity) for the Mental health and Physical Component Score (PCS) domains.
The model is adjusted for age and number of medication (Meds) and results presented as beta coefficients with 95% confidence intervals.
Table 3.
Health-related quality of life (HRQoL) between two different BMI categories in the group with obesity (BASUN).
Mean values are given for all RAND-36 scales and SRH-VAS, unless otherwise specified.